Clinical trial
The Role of Nebulized Budesonide in the Treatment of Acute Exacerbations of COPD
NCT00274222 · Inonu University, Other · Terminated
Key facts
| NCT number | NCT00274222 |
|---|---|
| Title | The Role of Nebulized Budesonide in the Treatment of Acute Exacerbations of COPD |
| Lead sponsor | Inonu University, Other |
| Status | Terminated |
| Study type | Observational |
| Conditions | COPD Acute Exacerbation |
| Enrollment | 120 |
| Start date | Jan 1, 2003 |
| Completion | Oct 1, 2005 |
| First posted | Jan 10, 2006 |
| Last update posted | Jan 10, 2006 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: